Comparison of triglyceride concentration with lipemic index in disorders of triglyceride and glycerol metabolism

Clinical Chemistry and Laboratory Medicine

Volumn 44, Issue 2, 2006, Pages 220-222

  De Haene, Heide ^a   Taes, Youri ^a   Christophe, Armand ^a   Delanghe, Joris ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Glycerol kinase deficiency; Hyperlipoproteinemia; Triglycerides; Very low density lipoprotein

Indexed keywords

GLYCEROL; GLYCEROL KINASE; SODIUM CHLORIDE; TRIACYLGLYCEROL;

ALCOHOL METABOLISM; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DILUTION; ERROR; GLYCEROL KINASE DEFICIENCY; HUMAN; HYPERLIPIDEMIA; HYPERLIPOPROTEINEMIA TYPE 1; HYPERLIPOPROTEINEMIA TYPE 4; HYPERLIPOPROTEINEMIA TYPE 5; LIPID METABOLISM; MAJOR CLINICAL STUDY; METABOLIC DISORDER; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; TURBIDIMETRY;

GLYCEROL KINASE; HUMANS; HYPERLIPIDEMIAS; HYPERLIPOPROTEINEMIAS; LIPOPROTEINS; METABOLIC DISEASES; TRIGLYCERIDES;

EID: 32544438605     PISSN: 14346621     EISSN: 14346621     Source Type: Journal    
DOI: 10.1515/CCLM.2006.040     Document Type: Article

References (15)

1. Kwiterovich PO Jr. The metabolic pathways of high-density lipoprotein, low-density lipoprotein, and triglycerides: a current review. Am J Cardiol 2000;21:5L-10L.
2. Karpe F, Hellenius ML, Hamsten A. Differences in postprandial concentrations of very-low-density lipoprotein and chylomicron remnants between normotriglyceridemic and hypertriglyceridemic men with and without cor onary heart disease. Metabolism 1999;48:301-7.
3. Fredrickson DS. Phenotyping. On reaching base camp (1950-1975). Circulation 1993;87:III1-15.
4. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996;3:213-29.
5. Mahley RW, Rall SC Jr. Type III hyperlipidemia (dysbetalipoproteinemia): the role of apolipoprotein E in normal and abnormal lipoprotein metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. New York, NY: McGraw-Hill, 2001:2835-63.
6. Colhoun HM, Otvos JD, Rubens MB, Taskinen MR, Underwood SR, Fuller JH. Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes. Diabetes 2002;51:1949-56.
7. Freedman DS, Otvos JD, Jeyarajah EJ, Barboriak JJ, Anderson AJ, Wells A. Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease. Arterioscler Thromb Vasc Biol 1998;18:1046-53.
8. Pozharski EV, McWilliams L, MacDonald RC. Relationship between turbidity of lipid vesicle suspensions and particle size. Anal Biochem 2001;291:158-62.
9. Grafmeyer D, Bondon M, Manchon M, Levillain P. The influence of bilirubin, haemolysis and turbidity on 20 analytical tests performed on automatic analysers. Results of an interlaboratory study. Eur J Clin Chem Clin Biochem 1995;33:31-52.
10. Pearson JR, Wells R, Wells A. Serum index identifies lipemic samples causing interference with bilirubin assay on Hitachi 717. Clin Chem 1991;37:2014-5.
11. Sampson M, Ruddel M, Elin RJ. Effects of specimen turbidity and glycerol concentration on nine enzymatic methods for triglyceride determination. Clin Chem 1994;40:221-6.
12. Walker AP, Muscatelli F, Stafford AN, Chelly J, Dahl N, Blomquist HK, et al. Mutations and phenotype in isolated glycerol kinase deficiency. Am J Hum Genet 1996;58:1205-11.
13. Wahlefeld AW, Bergmayer HU. Methods of enzymatic analysis 2. New York, NY: Academic Press, 1974:1831.
14. Esterbauer H, Striegl G, Puhl H, Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun 1989;6:67-75.
15. Brunzell JD, Deeb SS. Familial lipoprotein lipase deficiency, apo C-II deficiency, and hepatic lipase deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. New York, NY: McGraw-Hill, 2001:2789-816.